Barclays’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.3M Buy
492,814
+183,322
+59% +$6.06M ﹤0.01% 903
2025
Q1
$12.4M Sell
309,492
-78,641
-20% -$3.16M ﹤0.01% 910
2024
Q4
$18.3M Buy
388,133
+11,137
+3% +$524K 0.01% 815
2024
Q3
$19.9M Buy
376,996
+94,618
+34% +$5M 0.01% 748
2024
Q2
$15.3M Sell
282,378
-479,869
-63% -$26M ﹤0.01% 774
2024
Q1
$53.4M Buy
762,247
+297,524
+64% +$20.9M 0.02% 482
2023
Q4
$38.8M Sell
464,723
-107,544
-19% -$8.98M 0.01% 571
2023
Q3
$16.9M Buy
572,267
+426,921
+294% +$12.6M 0.01% 717
2023
Q2
$4.74M Sell
145,346
-195,926
-57% -$6.39M ﹤0.01% 1251
2023
Q1
$12M Sell
341,272
-55,915
-14% -$1.97M 0.01% 753
2022
Q4
$18.2M Sell
397,187
-4,066
-1% -$186K 0.01% 671
2022
Q3
$19.4M Buy
401,253
+72,972
+22% +$3.54M 0.02% 595
2022
Q2
$12.9M Buy
328,281
+247,104
+304% +$9.71M 0.01% 737
2022
Q1
$2.99M Sell
81,177
-24,412
-23% -$899K ﹤0.01% 1482
2021
Q4
$4.81M Buy
105,589
+22,295
+27% +$1.02M ﹤0.01% 1258
2021
Q3
$2.98M Buy
83,294
+30,153
+57% +$1.08M ﹤0.01% 1597
2021
Q2
$1.05M Sell
53,141
-82,746
-61% -$1.64M ﹤0.01% 2091
2021
Q1
$3.16M Sell
135,887
-49,445
-27% -$1.15M ﹤0.01% 1534
2020
Q4
$3.85M Sell
185,332
-9,463
-5% -$197K ﹤0.01% 1153
2020
Q3
$4.22M Buy
194,795
+61,488
+46% +$1.33M ﹤0.01% 1054
2020
Q2
$3.14M Buy
133,307
+84,397
+173% +$1.99M ﹤0.01% 1188
2020
Q1
$577K Sell
48,910
-38,181
-44% -$450K ﹤0.01% 2052
2019
Q4
$924K Sell
87,091
-24,651
-22% -$262K ﹤0.01% 2343
2019
Q3
$1.27M Buy
111,742
+46,783
+72% +$533K ﹤0.01% 2102
2019
Q2
$731K Buy
64,959
+31,128
+92% +$350K ﹤0.01% 2533
2019
Q1
$274K Buy
33,831
+10,782
+47% +$87.3K ﹤0.01% 2892
2018
Q4
$145K Sell
23,049
-32,952
-59% -$207K ﹤0.01% 2835
2018
Q3
$552K Buy
56,001
+31,669
+130% +$312K ﹤0.01% 2583
2018
Q2
$202K Buy
24,332
+721
+3% +$5.99K ﹤0.01% 2748
2018
Q1
$171K Buy
23,611
+4,314
+22% +$31.2K ﹤0.01% 2916
2017
Q4
$157K Buy
19,297
+3,794
+24% +$30.9K ﹤0.01% 2788
2017
Q3
$225K Sell
15,503
-8,963
-37% -$130K ﹤0.01% 2330
2017
Q2
$296K Buy
24,466
+17,064
+231% +$206K ﹤0.01% 2214
2017
Q1
$95K Sell
7,402
-7,922
-52% -$102K ﹤0.01% 2856
2016
Q4
$186K Buy
15,324
+4,944
+48% +$60K ﹤0.01% 2329
2016
Q3
$96K Buy
10,380
+2,666
+35% +$24.7K ﹤0.01% 2452
2016
Q2
$73K Buy
7,714
+76
+1% +$719 ﹤0.01% 2464
2016
Q1
$53K Buy
7,638
+7,510
+5,867% +$52.1K ﹤0.01% 2507
2015
Q4
$1K Sell
128
-54
-30% -$422 ﹤0.01% 3080
2015
Q3
$1K Sell
182
-577
-76% -$3.17K ﹤0.01% 3683
2015
Q2
$5K Sell
759
-3,596
-83% -$23.7K ﹤0.01% 3591
2015
Q1
$27K Sell
4,355
-923
-17% -$5.72K ﹤0.01% 2998
2014
Q4
$42K Sell
5,278
-29,642
-85% -$236K ﹤0.01% 3101
2014
Q3
$104K Buy
34,920
+34,360
+6,136% +$102K ﹤0.01% 2613
2014
Q2
$2K Sell
560
-88,003
-99% -$314K ﹤0.01% 4122
2014
Q1
$797K Buy
88,563
+87,973
+14,911% +$792K ﹤0.01% 1779
2013
Q4
$3K Sell
590
-281
-32% -$1.43K ﹤0.01% 4108
2013
Q3
$6K Buy
+871
New +$6K ﹤0.01% 3755